Tranexamic acid for the prevention and treatment of postpartum haemorrhage

British Journal of Anaesthesia

Volumn 114, Issue 4, 2015, Pages 576-587

  Sentilhes, L ^a   Lasocki, S ^a   Ducloy Bouthors, A S ^b   Deruelle, P ^b   Dreyfus, M ^c   Perrotin, F ^d   Goffinet, F ^e,f   Deneux Tharaux, C ^f  

^a ANGERS UNIVERSITY HOSPITAL   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c CAEN UNIVERSITY HOSPITAL   (France)

^d UNIVERSITÉ DE TOURS   (France)

^e Cochin University Hospital ^*  (France)

^f PARIS DESCARTES UNIVERSITY   (France)

Author keywords

caesarean and vaginal deliveries; postpartumhaemorrhage; prevention; tranexamic acid; treatment

Indexed keywords

METHYLERGOMETRINE; OXYTOCIN; PLACEBO; TRANEXAMIC ACID; ANTIFIBRINOLYTIC AGENT;

CESAREAN SECTION; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; DRUG MEGADOSE; DRUG SAFETY; EVIDENCE BASED MEDICINE; GASTROINTESTINAL SYMPTOM; HUMAN; LOADING DRUG DOSE; META ANALYSIS; NAUSEA; PLACENTAL DELIVERY; POSTPARTUM HEMORRHAGE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW; THROMBOEMBOLISM; THROMBOSIS; TONIC CLONIC SEIZURE; TREATMENT OUTCOME; VAGINAL DELIVERY; VENOUS THROMBOEMBOLISM; VOMITING; DRUG EFFECTS; FEMALE; FETUS; PREGNANCY;

ANTIFIBRINOLYTIC AGENTS; CESAREAN SECTION; FEMALE; FETUS; HUMANS; POSTPARTUM HEMORRHAGE; PREGNANCY; TRANEXAMIC ACID;

EID: 84926653427     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aeu448     Document Type: Review

References (92)

1. World Health Organization. Managing complications in pregnancy and childbirth. Geneva:World Health Organization, 2000
2. Atrash HK, Alexander S, Berg CJ. Maternal mortality in developed countries: not just a concern of the past. Obstet Gynecol 1995; 86: 700-5
3. KhanKS,Wojdyla D, Say L,Gülmezoglu AM, VanLook PFA.WHOanalysis of causes ofmaternal death: a systematic review. Lancet 2006; 367: 1066-74
4. Deneux-Tharaux C, Berg C, Bouvier-Colle M-H, et al. Underreporting of pregnancy-related mortality in the United States and Europe. Obstet Gynecol 2005; 106: 684-92
5. Saucedo M, Deneux-Tharaux C, Bouvier-Colle M-H. French National Experts Committee onMaternal Mortality. Ten years of confidential inquiries into maternal deaths in France, 1998-2007. Obstet Gynecol 2013; 122: 752-60
6. Bouvier-Colle MH, Deneux-Tharaux C, Saucedo M. Report of the National Expert Committee on Maternal Mortality (CNEMM), France, 2001-2006. Saint-Maurice: Institut de veille sanitaire; 2011. http://www.invs.sante.fr/publications/2010/mortalite-maternelle/rapport-mortalite-maternelle-anglais.pdf (accessed 15 December 2014)
7. Cantwell R, Clutton-Brock T, Cooper G, et al. Saving mothers' lives: reviewing maternal deaths to make motherhood safer: 2006-2008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG Int J Obstet Gynaecol 2011; 118(Suppl 1): 1-203
8. Bais JMJ, Eskes M, Pel M, Bonsel GJ, Bleker OP. Postpartum haemorrhage in nulliparous women: incidence and risk factors in low and high risk women. A Dutch population-based cohort study on standard & ge;500 ml) and severe (& ge;1000 ml) postpartum haemorrhage. Eur J Obstet Gynecol Reprod Biol 2004; 115: 166-72
9. Calvert C, Thomas SL, Ronsmans C, Wagner KS, Adler AJ, Filippi V. Identifying regional variation in the prevalence of postpartum haemorrhage: a systematic review and meta-analysis. PLoS One 2012; 7: e41114
10. Carroli G, Cuesta C, Abalos E, Gulmezoglu AM. Epidemiology of postpartum haemorrhage: a systematic review. Best Pract Res Clin Obstet Gynaecol 2008; 22: 999-1012
11. Joseph KS, Rouleau J, Kramer MS, et al. Investigation of an increase in postpartum haemorrhage in Canada. BJOG Int J Obstet Gynaecol 2007; 114: 751-9
12. Ford JB,Roberts CL, SimpsonJM,VaughanJ, CameronCA. Increased postpartum haemorrhage rates in Australia. Int J Gynaecol Obstet Off Organ Int Fed Gynaecol Obstet 2007; 98: 237-43
13. Callaghan WM, Kuklina EV, Berg CJ. Trends in postpartum haemorrhage: United States, 1994-2006. Am J Obstet Gynecol 2010; 202: 353.e1-6
14. Deneux-Tharaux C, Dupont C, Colin C, et al. Multifaceted intervention to decrease the rate of severe postpartum haemorrhage: the PITHAGORE6 cluster-randomised controlled trial. BJOG Int J Obstet Gynaecol 2010; 117: 1278-87
15. Kramer MS, Berg C, Abenhaim H, et al. Incidence, risk factors, and temporal trends in severe postpartum haemorrhage. Am J Obstet Gynecol 2013; 209: 449.e1-7
16. Bateman BT, Berman MF, Riley LE, Leffert LR. The epidemiology of postpartum haemorrhage in a large, nationwide sample of deliveries. Anesth Analg 2010; 110: 1368-73
17. Brace V, Penney G, Hall M.Quantifying severe maternal morbidity: a Scottish population study. BJOG Int J Obstet Gynaecol 2004; 111: 481-4
18. Callaghan WM, Mackay AP, Berg CJ. Identification of severematernal morbidity during delivery hospitalizations, United States, 1991-2003. Am J Obstet Gynecol 2008; 199: 133.e1-8
19. Waterstone M, Bewley S, Wolfe C. Incidence and predictors of severe obstetric morbidity: case-control study. BMJ 2001; 322: 1089-93; discussion 1093-1094
20. Wen SW, Huang L, Liston R, et al. Severe maternal morbidity in Canada, 1991-2001. CMAJ 2005; 173: 759-64
21. Al-Zirqi I, Vangen S, Forsen L, Stray-Pedersen B. Prevalence and risk factors of severe obstetric haemorrhage. BJOG Int J Obstet Gynaecol 2008; 115: 1265-72
22. Combs CA, Murphy EL, Laros RK Jr. Factors associated with haemorrhage in caesarean deliveries. Obstet Gynecol 1991; 77: 77-82
23. Combs CA, Murphy EL, Laros RK Jr. Factors associated with postpartum haemorrhage with vaginal birth. Obstet Gynecol 1991; 77: 69-76
24. Sosa CG, Althabe F, Belizán JM, Buekens P. Risk factors for postpartum haemorrhage in vaginal deliveries in a Latin-American population. Obstet Gynecol 2009; 113: 1313-9
25. Mathai M, Gülmezoglu AM, Hill S. Saving women's lives: evidencebased recommendations for the prevention of postpartum haemorrhage. BullWorld Health Org 2007; 85: 322-3
26. McCormick ML, Sanghvi HCG, Kinzie B, McIntosh N. Preventing postpartum haemorrhage in low-resource settings. Int J Gynaecol Obstet 2002; 77: 267-75
27. Goffinet F, Mercier F, Teyssier V, et al. Postpartum haemorrhage: recommendations for clinical practice by the CNGOF (December 2004). Gynecol Obstet Fertil 2005; 33: 268-74
28. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin: Clinical Management Guidelines for Obstetrician-Gynecologists Number 76, October 2006: postpartum haemorrhage. Obstet Gynecol 2006; 108: 1039-47
29. Royal College of Obstetricians and Gynaecologists. Prevention and management of postpartum haemorrhage. Guidelines no. 52. London: RCOG, 2009. Revised April 2011
30. World Health Organization. Recommendations for the prevention and treatment of postpartum haemorrhage. WHO, 2012. http:// www.who.int/reproductivehealth/publications/maternal-perinatal-health/9789241548502/en/
31. Lutomski JE, Byrne BM, Devane D, Greene RA. Increasing trends in atonic postpartumhaemorrhagein Ireland:an11-yearpopulationbased cohort study. BJOG 2012; 119: 306-14
32. Rogers J, Wood J, McCandlish R, Ayers S, Truesdale A, Elbourne D. Active versus expectant management of third stage of labour: the Hinchingbrooke randomised controlled trial. Lancet 1998; 351: 693-9
33. Begley CM, Gyte GML, Devane D, McGuireW,Weeks A. Active versus expectant management for women in the third stage of labour. Cochrane Database Syst Rev 2011; 11: CD007412
34. DeGroot AN, vanRoosmalenJ, vanDongenPW,BormGF.Aplacebocontrolled trial of oral ergometrine to reduce postpartum haemorrhage. Acta Obstet Gynecol Scand 1996; 75: 464-8
35. Nordström L, Fogelstam K, Fridman G, Larsson A, Rydhstroem H. Routine oxytocin in the third stage of labour: a placebo controlled randomised trial. Br J Obstet Gynaecol 1997; 104: 781-6
36. Jerbi M, Hidar S, Elmoueddeb S, Chaieb A, Khairi H. Oxytocin in the third stage of labor. Int J Gynaecol Obstet 2007; 96: 198-9
37. Abdel-Aleem H, Singata M, Abdel-Aleem M, Mshweshwe N, Williams X, Hofmeyr GJ. Uterine massage to reduce postpartum haemorrhage after vaginal delivery. Int J Gynaecol Obstet 2010; 111: 32-6
38. Westhoff G, Cotter AM, Tolosa JE. Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage. Cochrane Database Syst Rev 2013; 10: CD001808
39. Deneux-Tharaux C, Sentilhes L, Maillard F, et al. Effect of routine controlled cord traction as part of the active management of the third stage of labour on postpartum haemorrhage: multicentre randomised controlled trial (TRACOR). BMJ 2013; 346: f1541
40. Gülmezoglu AM, Lumbiganon P, Landoulsi S, et al. Active management of the third stage of labour with and without controlled cord traction: a randomised, controlled, non-inferiority trial. Lancet 2012; 379: 1721-7
41. Hutton EK, HassanES. Late vs earlyclamping of the umbilical cord in full-term neonates: systematic review and meta-analysis of controlled trials. JAMA 2007; 297: 1241-52
42. Andersson O, Hellström-Westas L, Andersson D, Domellöf M. Effect of delayed versus early umbilical cord clamping on neonatal outcomes and iron status at months: a randomised controlled trial. BMJ 2011; 343: d7157
43. McDonald SJ, Middleton P, Dowswell T, Morris PS. Effect of timing of umbilical cord clamping of term infants on maternal and neonatal outcomes. Cochrane Database Syst Rev 2013; 7: CD004074
44. Lalonde A, Daviss BA, Acosta A, Herschderfer K. Postpartum haemorrhage today: ICM/FIGO initiative 2004-2006. Int J Gynaecol Obstet Off Organ Int Fed Gynaecol Obstet 2006; 94: 243-53
45. Chen M, Chang Q, Duan T, He J, Zhang L, Liu X. Uterine massage to reduce blood loss after vaginal delivery: a randomized controlled trial. Obstet Gynecol 2013; 122: 290-5
46. Hofmeyr GJ, Abdel-AleemH, Abdel-AleemMA. Uterine massage for preventing postpartum haemorrhage. Cochrane Database Syst Rev 2013; 7: CD006431
47. Prentice CR. Basis of antifibrinolytic therapy. J Clin Pathol Suppl (R Coll Pathol) 1980; 14: 35-40
48. Novikova N,HofmeyrGJ. Tranexamic acid for preventing postpartum haemorrhage. Cochrane Database Syst Rev 2010; 7: CD007872
49. Hellgren M. Hemostasis during normal pregnancy and puerperium. Semin Thromb Hemost 2003; 29: 125-30
50. Charbit B, Mandelbrot L, Samain E, et al. The decrease of fibrinogen is an early predictor of the severity of postpartum haemorrhage. J Thromb Haemost 2007; 5: 266-73
51. Cortet M, Deneux-Tharaux C, Dupont C, et al. Association between fibrinogen level and severity of postpartum haemorrhage: secondary analysis of a prospective trial. Br J Anaesth 2012; 108: 984-9
52. Ducloy-Bouthors A-S, Jude B, Duhamel A, et al. High-dose tranexamic acid reduces blood loss in postpartum haemorrhage. Crit Care 2011; 15: R117
53. Dunn CJ, Goa KL. Tranexamic acid: a reviewof its use in surgery and other indications. Drugs 1999; 57: 1005-32
54. BolteAC, BournaL,VanGeijnHP. Medical therapies for primary postpartum haemorrhage. International Congress Series. Gynaecol Obstet Reprod Med Daily Pract 2005; 1279: 364-8
55. Bonnar J, Guillebaud J, Kasonde JM, Sheppard BL. Clinical applications of fibrinolytic inhibition in gynaecology. J Clin Pathol Suppl (R Coll Pathol) 1980; 14: 55-9
56. Peitsidis P, Kadir RA. Antifibrinolytic therapy with tranexamic acid in pregnancy and postpartum. Expert Opin Pharmacother 2011; 12: 503-16
57. Mercier FJ, Bonnet M-P. Use of clotting factorsand other prohaemostatic drugs for obstetric haemorrhage. Curr Opin Anaesthesiol 2010; 23: 310-6
58. Henry DA, Carless PA, Moxey AJ, et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2007; 3: CD001886
59. Ker K, Edwards P, Perel P, Shakur H, Roberts I. Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ 2012; 344: e3054
60. CRASH-2 trial collaborators Effects of tranexamic acid on death, vascular occlusive events, andblood transfusion in traumapatients with significant haemorrhage (CRASH-2): a randomised, placebocontrolled trial. Lancet 2010; 376: 23-32
61. Matteson KA, Rahn DD, Wheeler TL II, et al. Nonsurgical management of heavy menstrual bleeding: a systematic review. Obstet Gynecol 2013; 121: 632-43
62. Gai M, Wu L, Su Q, Tatsumoto K. Clinical observation of blood loss reduced by tranexamic acid during and after caesarean section: a multi-center, randomized trial. Eur J Obstet Gynecol Reprod Biol 2004; 112: 154-7
63. Gohel M, Patel P, Gupta A, Desai P. Efficacy of tranexamic acid in decreasing blood loss during and after caesarean section: a randomised case controlled prospective study. J Obstet Gynecol India 2007; 57: 227-30
64. Sekhavat L, Tabatabaii A, Dalili M, Farajkhoda T, Tafti AD. Efficacy of tranexamic acid in reducing blood loss after caesarean section. J Matern Fetal Neonatal Med 2009; 22: 72-5
65. Gungorduk K, Yildirim G, Asicioʇlu O, Gungorduk OC, Sudolmus S, Ark C. Efficacy of intravenous tranexamic acid in reducing blood loss after elective caesarean section: a prospective, randomized, double-blind, placebo-controlled study. Am J Perinatol 2011; 28: 233-40
66. Movafegh A, Eslamian L, Dorabadi A. Effect of intravenous tranexamic acid administration on blood loss during and after caesarean delivery. Int J Gynaecol Obstet 2011; 115: 224-6
67. Xu J, GaoW, Ju Y. Tranexamic acid for the prevention of postpartum haemorrhage after caesarean section: a double-blind randomization trial. Arch Gynecol Obstet 2013; 287: 463-8
68. Sentü rk MB, Cakmak Y, Yildiz G, Yildiz P. Tranexamic acid for caesarean section: a double-blind, placebo-controlled, randomized clinical trial. Arch Gynecol Obstet 2013; 287: 641-5
69. Shahid A, Khan A. Tranexamic acid in decreasing blood loss during and after caesarean section. J Coll Physicians Surg Pak 2013; 23: 459-62
70. Abdel-Aleem H, Alhusaini TK, Abdel-Aleem MA, Menoufy M, Gülmezoglu AM. Effectiveness of tranexamic acid on blood loss in patients undergoing elective caesareansection: randomized clinical trial. J Matern Fetal Neonatal Med 2013; 26: 1705-9
71. GoswamiU, Sarangi S, Gupta S, Babbar S.Comparative evaluation of two doses of tranexamic acid used prophylactically in anemic parturients for lower segment caesarean section: A double-blind randomized case control prospective trial. Saudi J Anaesth 2013; 7: 427-31
72. Yang H, Zheng S, Shi C. Clinical study on the efficacy of tranexamic acid in reducing postpartum blood lose: a randomized, comparative, multicenter trial. Zhonghua Fu Chan Ke Za Zhi 2001; 36: 590-2
73. Gungorduk K, Asicioʇ lu O, Yildirim G, Ark C, Tekirdaʇ AI, Besimoglu B. Can intravenous injection of tranexamic acid be used in routine practice with active management of the third stage of labor in vaginal delivery? A randomized controlled study. Am J Perinatol 2013; 30: 407-13
74. Ferrer P, Roberts I, Sydenham E, Blackhall K, Shakur H. Antifibrinolytic agents in post partum haemorrhage: a systematic review. BMC Pregnancy Childbirth 2009; 9: 29
75. Shakur H, Elbourne D, Gülmezoglu M, et al. TheWOMANTrial (World Maternal Antifibrinolytic Trial): tranexamicacid for the treatmentof postpartum haemorrhage: an international randomised, double blind placebo controlled trial. Trials 2010; 11: 40
76. World Health Organization. Summary of the report of the 18th meeting of the WHO Expert Committee on the Selection and Use of Essential Medicines, Accra, Ghana, 2011. http://www.who.int/ selection-medicines/committees/expert/18/en/index.html
77. National Collaborating Centre for Women's and Children's Health. Intrapartum care of healthy women and their babies during childbirth. Clinical Guidance RCGO Press, 2007
78. Cook L, Roberts I, WOMAN Trial Collaborators. Post-partum haemorrhage and the WOMAN trial. Int J Epidemiol 2010; 39: 949-50
79. KooJR, LeeYK,KimYS,ChoWY,KimHK,WonNH.Acuterenal cortical necrosis caused by an antifibrinolytic drug (tranexamic acid). Nephrol Dial Transplant 1999; 14: 750-2
80. Odabaş AR, Cetinkaya R, Selçuk Y, Kaya H, Coşkun U. Tranexamicacid-induced acute renal cortical necrosis in a patient with haemophilia A. Nephrol Dial Transplant 2001; 16: 189-90
81. Levin M-D, Betjes MGH, van der Kwast TH, Wenberg BL, LeebeekFWG.Acute renal cortex necrosis caused byarterial thrombosis during treatment for acute promyelocytic leukemia. Haematologica 2003; 88: ECR21
82. Charytan C, Purtilo D. Glomerular capillary thrombosis and acute renal failure after epsilon-amino caproic acid therapy. N Engl J Med 1969; 280: 1102-4
83. Purtilo DT, Constantian HM, DeGirolami E. Letter: Epsilon-aminocaproic acid in haematuria. Lancet 1975; 1: 755
84. Khan RU, El-Refaey H. Pathophysiology of postpartum haemorrhage and third stage of labor. In: Arulkumaran A, Karoshi M, Keith LG, Lalonde AB, B-Lynch C, eds. A Comprehensive Textbook of Postpartum Haemorrhage, 2nd edn. London: Sapiens Publishing, 2012; 94-100
85. Louden KA, Broughton Pipkin F, Symonds EM, et al. A randomized placebo-controlled study of the effect of low dose aspirin on platelet reactivity and serum thromboxane B2 production in nonpregnant women, in normal pregnancy, and in gestational hypertension. Br J Obstet Gynaecol 1992; 99: 371-6
86. Jackson E, Curtis KM, Gaffield ME. Risk of venous thromboembolism during the postpartum period: a systematic review. Obstet Gynecol 2011; 117: 691-703
87. Chugh KS, Jha V, SakhujaV, Joshi K. Acute renal cortical necrosis-a study of 113 patients. Ren Fail 1994; 16: 37-47
88. Keyl C, Uhl R, Beyersdorf F, et al. High-dose tranexamic acid is related to increased riskof generalized seizures after aortic valvereplacement. Eur J Cardiothorac Surg 2011; 39: e114-121
89. Furtmü ller R, Schlag MG, Berger M, et al. Tranexamic acid, a widely used antifibrinolytic agent, causes convulsions by a gammaaminobutyric acid(A) receptor antagonistic effect. J Pharmacol Exp Ther 2002; 31: 168-73
90. Kagoma YK, Crowther MA, Douketis J, Bhandari M, Eikelboom J, Lim W. Use of antifibrinolytic therapy to reduce transfusion in patients undergoing orthopedic surgery: a systematic review of randomized trials. Thromb Res 2009; 123: 687-96
91. Aronson JK. Tranexamic acid. In: Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions, 15th edn. New York: Elsevier, 2006: 3476-9
92. Walzman M, Bonnar J. Effect of tranexamic acid on the coagulation and fibrinolytic systems in pregnancy complicated by placental bleeding. Arch Toxicol Suppl 1982; 5: 214-20